| Literature DB >> 22674920 |
Lucy Yardley1, Fiona Barker, Ingrid Muller, David Turner, Sarah Kirby, Mark Mullee, Anna Morris, Paul Little.
Abstract
OBJECTIVE: To determine the clinical and cost effectiveness of booklet based vestibular rehabilitation with and without telephone support for chronic dizziness, compared with routine care.Entities:
Mesh:
Year: 2012 PMID: 22674920 PMCID: PMC3368486 DOI: 10.1136/bmj.e2237
Source DB: PubMed Journal: BMJ ISSN: 0959-8138

Fig 1 CONSORT diagram showing patient flow through trial
Baseline characteristics of participants. Data are no (%) unless stated otherwise
| Intervention arm | Total sample (n=337) | |||
|---|---|---|---|---|
| Routine care (n=112) | Booklet self management only (n=113) | Booklet self management with telephone support (n=112) | ||
| Male | 28 (25) | 40 (35) | 30 (27) | 98 (29) |
| Age, years (mean, standard deviation) | 58.2 (15.8) | 60.5 (15.2) | 59.5 (14.9) | 59.4 (15.3) |
| Left school aged <18 years | 80 (71) | 94/111* (85) | 95/110* (86) | 269/333* (81) |
| Post school education | 68 (61) | 62/111* (56) | 67/110* (61) | 197/333* (59) |
| Duration of dizziness, months (mean, standard deviation) | 67.9 (111.0) | 65 7 (75.6) | 65.8 (88.6) | 66.5 (93.0) |
| Consulted health professional in past year for dizziness | 90 (80) | 76 (67) | 69 (62) | 235 (70) |
| Prescribed medication for dizziness | 65 (58) | 63 (56) | 62 (55) | 190 (56) |
| Exceeded screening threshold for anxiety on hospital anxiety and depression scale | 44 (39) | 46 (41) | 53 (47) | 143 (42) |
| Exceeded screening threshold for depression on hospital anxiety and depression scale | 27 (24) | 17 (15) | 21 (19) | 65 (19) |
| Vertigo symptom scale-short form (mean, standard deviation) | 13.8 (10.7) | 12.6 (7.7) | 13.4 (9.6) | 13.5 (9.6) |
*Data not complete for all participants randomised.
Comparison of outcomes at 12 week follow-up
| Intervention (mean score (standard deviation), no) | Comparison (adjusted mean difference (95% CI), P)* | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Routine care | Booklet self management with telephone support | Booklet self management only | Routine care versus booklet self management with telephone support | Routine care versus booklet self management only | |||||||
| Baseline | 12 weeks | Baseline | 12 weeks | Baseline | 12 weeks | ||||||
| Vertigo symptom scale-short form | 13.7 (10.7), n=98 | 10.5 (8.7), n=98 | 12.9 (8.9), n=85 | 8.3 (7.9), n=85 | 12.2 (7.9), n=92 | 9.1 (7.6), n=92 | −1.79 (−3.69 tο 0.11), P=0.064 | −0.59 (−2.45 tο1.27), P=0.532 | |||
| Patients reporting subjective improvement | — | 40/107 (37)† | — | 57/100 (57)† | — | 62/105 (59)† | 2.25 (1.28 to 3.94)‡, P=0.005 | 2.41 (1.39 tο 4.20)‡, P=0.002 | |||
| Vertigo balance subscale | 8.3 (6.7), n=98 | 5.7 (5.1), n=98 | 7.5 (6.1), n=85 | 4.6 (5.2), n=85 | 7.7 (5.7), n=92 | 5.0 (5.1), n=92 | −0.74 (−1.98 tο 0.51), P=0.246 | −0.46 (−1.67 tο 0.75), P=0.454 | |||
| Autonomic anxiety subscale | 5.4 (5.0), n=98 | 4.8 (4.5), n=98 | 5.4 (4.4), n=85 | 3.7 (3.9), n=85 | 4.4 (3.6), n=92 | 4.1 (3.8), n=92 | −1.11 (−2.03 tο −0.20), P=0.017 | −0.08 (−1.00 tο 0.82), P=0.869 | |||
| Dizziness handicap inventory | 32.9 (18.4), n=96 | 28.2 (18.7), n=96 | 33.1 (19.7), n=85 | 26.2 (21.3), n=85 | 33.0 (17.7), n=92 | 26.2 (18.6), n=92 | −2.25 (−5.98 tο 1.47), P=0.234 | −2.06 (−5.74 tο 1.61), P=0.269 | |||
| Hospital anxiety and depression scale | |||||||||||
| Anxiety | 6.91 (4.30), n=97 | 6.3 (4.13), n=97 | 6.80 (4.18), n=85 | 5.79 (4.27), n=85 | 6.62 (3.93), n=92 | 6.00 (4.17), n=92 | −0.46 (−1.21 tο 0.29), P=0.228 | −0.12 (−0.88 tο 0.65), P=0.763 | |||
| Depression | 4.23 (3.42), n=97 | 4.03 (3.44), n=97 | 4.12 (3.22), n=85 | 3.92 (3.56), n=85 | 4.26 (3.47), n=92 | 3.77 (3.54), n=92 | −0.02 (−0.66 tο 0.62), P=0.954 | −0.28 (−0.93 tο 0.37), P=0.396 | |||
| EQ-5D | 0.79 (0.22), n=94 | 0.79 (0.27), n=94 | 0.75 (0.27), n=84 | 0.80 (0.24), n=84 | 0.78 (0.24), n=89 | 0.82 (0.19), n=89 | 0.04 (−0.02 tο 0.10), P=0.156 | 0.04 (−0.02 tο 0.09), P=0.179 | |||
*All analyses adjusted for baseline levels of the stratification variable, the vertigo symptom scale-short form, and for baseline levels of the dependent variable.
†Data are reporting/total number of patients (%).
‡Data are odds ratio (95% confidence interval).
Comparison of outcomes at one year follow-up
| Intervention (mean score (standard deviation), no) | Comparison (adjusted mean difference (95% CI), P)* | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Routine care | Booklet self management with telephone support | Booklet self management only | Routine care versus booklet self management with telephone support | Routine care versus booklet self management only | |||||
| Baseline | One year | Baseline | One year | Baseline | One year | ||||
| Vertigo symptom scale-short form | 13.8 (10.7), n=89 | 11.0 (8.7), n=89 | 13.4 (10.0), n=86 | 8.3 (8.5), n=86 | 11.8 (7.9), n=88 | 7.6 (6.2), n=88 | −2.52 (−4.52 to −0.51), P=0.014 | −2.43 (−4.27 to −0.60), P=0.010 | |
| Patients reporting subjective improvement | — | 47/99 (47%)† | — | 66/95 (69%)† | — | 60/100 (60%)† | 2.56 (1.41 to 4.66)‡, P=0.002 | 1.63 (0.93 to 2.87)‡, P=0.091 | |
| Vertigo balance subscale | 8.2 (6.6), n=89 | 5.7 (4.9), n=89 | 7.7 (6.7), n=86 | 4.6 (5.5), n=86 | 7.2 (5.5), n=88 | 4.3 (4.0), n=88 | −1.07 (−2.2 to 1.0), P=0.073 | −0.92 (−2.23 to 0.39), P=0.168 | |
| Autonomic anxiety subscale | 5.6 (5.1), n=89 | 5.3 (4.6), n=89 | 5.6 (4.8), n=86 | 3.6 (4.0), n=86 | 4.5 (3.7), n=88 | 3.3 (3.2), n=88 | −1.64 (−2.60 tο −0.68), P=0.001 | −1.38 (−2.31 tο −0.46) P=0.004 | |
| Dizziness handicap inventory | 33.7 (18.1), n=89 | 29.2 (18.8), n=89 | 33.7 (18.1), n=86 | 29.2 (18.8), n=86 | 31.2 (17.6), n=88 | 23.0 (17.7), n=88 | −4.27 (−8.70 to −0.74), P=0.020 | −4.37 (−8.5 to −0.21) P=0.040 | |
| Hospital anxiety and depression scale | |||||||||
| Anxiety | 7.15 (4.27), n=89 | 7.01 (4.27), n=89 | 6.79 (4.33), n=86 | 5.66 (4.40), n=86 | 6.68 (3.99), n=88 | 6.03 (4.51), n=88 | −1.05 (−1.89 to −0.22), P=0.014 | −0.59 (−1.48 to 0.31), P=0.200 | |
| Depression | 4.51 (3.68), n=89 | 4.60 (4.02), n=89 | 4.11 (3.52), n=86 | 3.41 (3.41), n=86 | 4.00 (3.44), n=88 | 3.82 (3.62), n=88 | −0.87 (−1.57 to −0.17), P=0.016 | −0.35 (−1.13 to 0.44), P=0.387 | |
| EQ-5D | 0.79 (0.21), n=86 | 0.79 (0.26), n=86 | 0.75 (0.29), n=85 | 0.80 (0.28), n=85 | 0.83 (0.23), n=85 | 0.82 (0.18), n=85 | 0.04 (−0.01 to 0.10), P=0.107 | 0.02 (−0.03 to 0.07), P=0.343 | |
*All analyses adjusted for baseline levels of the stratification variable, the vertigo symptom scale-short form, and for baseline levels of the dependent variable.
†Data are reporting/total number of patients (%).
‡Data are odds ratio (95% confidence interval).

Fig 2 Pattern of subjective improvement at one year follow-up
Bootstrapped cost effectiveness analysis (complete case analysis)
| QALY or point change on vertigo symptom scale-short form (95% percentiles) | Total costs (95% percentiles) | Incremental QALY or vertigo symptom scale-short form | Incremental costs | Incremental cost effectiveness ratio | |
|---|---|---|---|---|---|
| Cost per QALY | |||||
| Routine care | 0.80 (0.76 to 0.85) | £35 (20 to 51) | Dominated* | ||
| Booklet self management only | 0.83 (0.79 to 0.86) | £31 (12 to 55) | — | ||
| Booklet self management with telephone support | 0.85 (0.80 to 0.90) | £60 (46 to 77) | 0.022 | £29 | £1363 |
| Cost per point change on vertigo symptom scale-short form | |||||
| Routine care | 3.2 (1.4 to 5.0) | £35 (21 to 51) | Dominated* | ||
| Booklet self management only | 4.2 (2.7 to 5.8) | £31 (12 to 55) | — | ||
| Booklet self management with telephone support | 4.5 (2.7 to 6.3) | £60 (46 to 77) | 0.227 | £29 | £129 |
*Booklet self management only group dominates the routine care group—that is, routine care was less effective and slightly more costly than booklet self management only. It is considered standard practice to compare groups with the next best option that is not dominated.57 Therefore, booklet self management with telephone support was compared with booklet self management only.

Fig 3 Cost effectiveness acceptability curve showing change in the probability of cost effectiveness as the value of a QALY changes (NHS costs only)